Trials / Completed
CompletedNCT05246631
Haloperidol and Dexamethasone Towards Postoperative Nausea and Pain in Adult After Laparoscopy
Haloperidol Compared to Dexamethasone in Lowering Postoperative Nausea and Vomiting and Pain in Adult After Laparoscopy
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Indonesia University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study aim to find out the effectiveness of 1 mg intravenous haloperidol compared to 5 mg intravenous dexamethasone to prevent the occurrence of nausea and vomiting also as pain control in adult patients after laparoscopic surgery.
Detailed description
Eighty subjects (n=40 for each group) scheduled for laparoscopic-assisted surgery were enrolled in a randomized double-blind clinical trial. One milligram intravenous haloperidol was given one hour before the end of surgery, while 5 mg intravenous dexamethasone was given right after induction. The occurrence of Postoperative Nausea and Vomiting (PONV) and visual analog scale (VAS) pain score were recorded.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexamethasone injection | Group A consisted of patients given 5 mg intravenous dexamethasone after induction. |
| DRUG | Haloperidol Injection | Group B consisted of patients given 1 mg intravenous haloperidol one hour before the surgery ended |
Timeline
- Start date
- 2020-01-01
- Primary completion
- 2020-03-30
- Completion
- 2020-07-30
- First posted
- 2022-02-18
- Last updated
- 2022-02-18
Locations
1 site across 1 country: Indonesia
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05246631. Inclusion in this directory is not an endorsement.